Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.32−0.02 (-5.70%)
Close on Nov 20, 2026Market cap $13.96MP/E –Yield –
Estrella Immunopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Estrella Immunopharma's market cap was $21.52M on Nov 11, 2026, against $77.25M a year earlier. Over the last 5 years it ranged from $2.27M to $88.60M, with a median of $33.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.52M | -62.3% |
| 2025 | Dec 31, 2025 | $57.11M | +30.0% |
| 2024 | Dec 31, 2024 | $43.93M | +12.4% |
| 2023 | Dec 29, 2023 | $39.07M | +167.5% |
| 2022 | Dec 30, 2022 | $14.61M | +3.8% |
| 2021 | Dec 31, 2021 | $14.07M | – |
See a number that looks wrong?